BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 21498666)

  • 1. Cutting edge: PHLPP regulates the development, function, and molecular signaling pathways of regulatory T cells.
    Patterson SJ; Han JM; Garcia R; Assi K; Gao T; O'Neill A; Newton AC; Levings MK
    J Immunol; 2011 May; 186(10):5533-7. PubMed ID: 21498666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR.
    Sauer S; Bruno L; Hertweck A; Finlay D; Leleu M; Spivakov M; Knight ZA; Cobb BS; Cantrell D; O'Connor E; Shokat KM; Fisher AG; Merkenschlager M
    Proc Natl Acad Sci U S A; 2008 Jun; 105(22):7797-802. PubMed ID: 18509048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mislocalization of the E3 ligase, β-transducin repeat-containing protein 1 (β-TrCP1), in glioblastoma uncouples negative feedback between the pleckstrin homology domain leucine-rich repeat protein phosphatase 1 (PHLPP1) and Akt.
    Warfel NA; Niederst M; Stevens MW; Brennan PM; Frame MC; Newton AC
    J Biol Chem; 2011 Jun; 286(22):19777-88. PubMed ID: 21454620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PHLPPing the Script: Emerging Roles of PHLPP Phosphatases in Cell Signaling.
    Baffi TR; Cohen-Katsenelson K; Newton AC
    Annu Rev Pharmacol Toxicol; 2021 Jan; 61():723-743. PubMed ID: 32997603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the PHLPPside: Emerging roles of PHLPP phosphatases in the heart.
    Lemoine KA; Fassas JM; Ohannesian SH; Purcell NH
    Cell Signal; 2021 Oct; 86():110097. PubMed ID: 34320369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PHLPP1 counter-regulates STAT1-mediated inflammatory signaling.
    Cohen Katsenelson K; Stender JD; Kawashima AT; Lordén G; Uchiyama S; Nizet V; Glass CK; Newton AC
    Elife; 2019 Aug; 8():. PubMed ID: 31408005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guide to virtual screening: application to the Akt phosphatase PHLPP.
    Sinko W; Sierecki E; de Oliveira CA; McCammon JA
    Methods Mol Biol; 2012; 819():561-73. PubMed ID: 22183558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Akt-ing up on SRPK1: oncogene or tumor suppressor?
    Toker A; Chin YR
    Mol Cell; 2014 May; 54(3):329-30. PubMed ID: 24813709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palmitoylated SCP1 is targeted to the plasma membrane and negatively regulates angiogenesis.
    Liao P; Wang W; Li Y; Wang R; Jin J; Pang W; Chen Y; Shen M; Wang X; Jiang D; Pang J; Liu M; Lin X; Feng XH; Wang P; Ge X
    Elife; 2017 Mar; 6():. PubMed ID: 28440748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting MgrA-mediated virulence regulation in Staphylococcus aureus.
    Sun F; Zhou L; Zhao BC; Deng X; Cho H; Yi C; Jian X; Song CX; Luan CH; Bae T; Li Z; He C
    Chem Biol; 2011 Aug; 18(8):1032-41. PubMed ID: 21867918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential N-glycosylation of a monoclonal antibody expressed in tobacco leaves with and without endoplasmic reticulum retention signal apparently induces similar in vivo stability in mice.
    Triguero A; Cabrera G; Rodríguez M; Soto J; Zamora Y; Pérez M; Wormald MR; Cremata JA
    Plant Biotechnol J; 2011 Dec; 9(9):1120-30. PubMed ID: 21819534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia.
    Zuber J; Shi J; Wang E; Rappaport AR; Herrmann H; Sison EA; Magoon D; Qi J; Blatt K; Wunderlich M; Taylor MJ; Johns C; Chicas A; Mulloy JC; Kogan SC; Brown P; Valent P; Bradner JE; Lowe SW; Vakoc CR
    Nature; 2011 Aug; 478(7370):524-8. PubMed ID: 21814200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility.
    Evans DM; Spencer CC; Pointon JJ; Su Z; Harvey D; Kochan G; Oppermann U; Dilthey A; Pirinen M; Stone MA; Appleton L; Moutsianas L; Leslie S; Wordsworth T; Kenna TJ; Karaderi T; Thomas GP; Ward MM; Weisman MH; Farrar C; Bradbury LA; Danoy P; Inman RD; Maksymowych W; Gladman D; Rahman P; ; Morgan A; Marzo-Ortega H; Bowness P; Gaffney K; Gaston JS; Smith M; Bruges-Armas J; Couto AR; Sorrentino R; Paladini F; Ferreira MA; Xu H; Liu Y; Jiang L; Lopez-Larrea C; Díaz-Peña R; López-Vázquez A; Zayats T; Band G; Bellenguez C; Blackburn H; Blackwell JM; Bramon E; Bumpstead SJ; Casas JP; Corvin A; Craddock N; Deloukas P; Dronov S; Duncanson A; Edkins S; Freeman C; Gillman M; Gray E; Gwilliam R; Hammond N; Hunt SE; Jankowski J; Jayakumar A; Langford C; Liddle J; Markus HS; Mathew CG; McCann OT; McCarthy MI; Palmer CN; Peltonen L; Plomin R; Potter SC; Rautanen A; Ravindrarajah R; Ricketts M; Samani N; Sawcer SJ; Strange A; Trembath RC; Viswanathan AC; Waller M; Weston P; Whittaker P; Widaa S; Wood NW; McVean G; Reveille JD; Wordsworth BP; Brown MA; Donnelly P; ;
    Nat Genet; 2011 Jul; 43(8):761-7. PubMed ID: 21743469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics and the environment converge to dysregulate N-glycosylation in multiple sclerosis.
    Mkhikian H; Grigorian A; Li CF; Chen HL; Newton B; Zhou RW; Beeton C; Torossian S; Tatarian GG; Lee SU; Lau K; Walker E; Siminovitch KA; Chandy KG; Yu Z; Dennis JW; Demetriou M
    Nat Commun; 2011; 2():334. PubMed ID: 21629267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantigen discovery with a synthetic human peptidome.
    Larman HB; Zhao Z; Laserson U; Li MZ; Ciccia A; Gakidis MA; Church GM; Kesari S; Leproust EM; Solimini NL; Elledge SJ
    Nat Biotechnol; 2011 May; 29(6):535-41. PubMed ID: 21602805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TSG-6 protein, a negative regulator of inflammatory arthritis, forms a ternary complex with murine mast cell tryptases and heparin.
    Nagyeri G; Radacs M; Ghassemi-Nejad S; Tryniszewska B; Olasz K; Hutas G; Gyorfy Z; Hascall VC; Glant TT; Mikecz K
    J Biol Chem; 2011 Jul; 286(26):23559-69. PubMed ID: 21566135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic siRNA silencing in inflammatory monocytes in mice.
    Leuschner F; Dutta P; Gorbatov R; Novobrantseva TI; Donahoe JS; Courties G; Lee KM; Kim JI; Markmann JF; Marinelli B; Panizzi P; Lee WW; Iwamoto Y; Milstein S; Epstein-Barash H; Cantley W; Wong J; Cortez-Retamozo V; Newton A; Love K; Libby P; Pittet MJ; Swirski FK; Koteliansky V; Langer R; Weissleder R; Anderson DG; Nahrendorf M
    Nat Biotechnol; 2011 Oct; 29(11):1005-10. PubMed ID: 21983520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13.
    Liu J; Xia H; Kim M; Xu L; Li Y; Zhang L; Cai Y; Norberg HV; Zhang T; Furuya T; Jin M; Zhu Z; Wang H; Yu J; Li Y; Hao Y; Choi A; Ke H; Ma D; Yuan J
    Cell; 2011 Sep; 147(1):223-34. PubMed ID: 21962518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic chromosome arms function in yeast and generate phenotypic diversity by design.
    Dymond JS; Richardson SM; Coombes CE; Babatz T; Muller H; Annaluru N; Blake WJ; Schwerzmann JW; Dai J; Lindstrom DL; Boeke AC; Gottschling DE; Chandrasegaran S; Bader JS; Boeke JD
    Nature; 2011 Sep; 477(7365):471-6. PubMed ID: 21918511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomal encapsulation of glucocorticoids alters their mode of action in the treatment of experimental autoimmune encephalomyelitis.
    Schweingruber N; Haine A; Tiede K; Karabinskaya A; van den Brandt J; Wüst S; Metselaar JM; Gold R; Tuckermann JP; Reichardt HM; Lühder F
    J Immunol; 2011 Oct; 187(8):4310-8. PubMed ID: 21918186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.